Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
TripAE
TripAE
Sponsor study identifier
observational
400
0 countries
N/A
Study Start
August 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Chronic obstructive pulmonary disease has become a serious global health care and public health problems due to its high prevalence, high morbidity and heavy economic burden. Acute exacerbation of chronic obstructive pulmonary disease is one of the most important causes of death in patients with COPD. Systemic corticosteroids therapy is recommended in COPD exacerbations. In clinical practice for the treatment of acute exacerbation of COPD, antibiotic application is still controversial. Evidence from current guideline is based on strict criteria from randomized controlled trials, thus the given condition is simplified. Patients meet the criteria account for the minority in the real world. Therefore, it is still not clear whether most patients benefit from the recommended treatment. In our design, hospitalized patients with acute exacerbation of COPD will be enrolled, with their treatment, arterial hypoxemia, recovery time and length of hospitalization being observed. The main purpose is to evaluate the benefit effect of current recommended treatment of acute exacerbation of COPD in the real world.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 9, 2014
Actual (reported)August 2014
Date type not reportedThis date has not been verified as actual or estimated.
August 18, 2014
Actual (reported)June 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
change of the score of COPD Assesment Test as a measurement of the overall condition of the patient
baseline, 1 month after dischahge, 2 months after discharge
change of the score of modified Medical British Research Council questionaire as a measurement of the overall condition of the patient
baseline, 1 month after discharge, 2 months after discharge
percentage of use of systemic corticosteroid in patients
8 months after the first enrollment
Patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease from 1st July, 2014 from Beijing Chao Yang Hospital
25-(OH)-VD3 and glycated albumin will be tested
Wang Ying, Master
Beijing Chao Yang Hospital
Huang Kewu, M.D.
Beijing Chao Yang Hospital
First Submitted
July 9, 2014
First Posted
August 18, 2014
Study Start
August 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
June 2015
Estimated (date passed)Identification of Volatile Organic Compounds in Exhaled Air During Exacerbation of Chronic Obstructive Pulmonary Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 18, 2014
Record last verified: 2014-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: